Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin specific peptidase 17 like family member 24 (USP17L24) is a cysteine-type deubiquitinating enzyme that removes conjugated ubiquitin from specific substrate proteins, thereby regulating cellular processes such as protein degradation, cell proliferation, cell cycle progression, apoptosis, migration, and responses to viral infection. It is primarily localized in the nucleolus and contributes to the positive regulation of epithelial cell apoptosis and protein catabolism via the ubiquitin-proteasome system. Disease associations include acute intermittent porphyria and processes linked to cancer biology due to its fundamental role in controlling protein turnover and signaling pathways.
Inhibition of deubiquitinase activity could reduce protein stabilization, influence apoptosis, and modulate cellular signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin specific peptidase 17 like family member 24 (USP17L24).